 |
Европейская академия
|
| В начало | Энциклопедия ЕАЕН | |
Энциклопедия Европейской академии естественных наук |
||
Bai Zongke
Dr. Bai Zongke, CEO of Shenzhen ZeYi Cell Therapy Group, holds a Ph.D. in Microbiology and Biochemical Pharmacy from China Pharmaceutical University. He is a dedicated researcher fervently working in the realms of early cancer screening, precise tumor treatments, and anti-aging. Dr. Bai Zongke is a distinguished expert in the field of preventive medicine.
Under his leadership, his team has developed an innovative early cancer screening technology known as "Five-Network Joint Screening," which can accurately detect cancerous cellular changes at an extremely early stage. Following the detection, the "Cell Pharmacy" technology, also pioneered by Dr. Bai Zongke's team, provides precise treatment, offering a beacon of hope for the majority of individuals at high risk of cancer to avoid the affliction and lead healthy lives.
In a relentless pursuit to better prevent tumors, Dr. Bai Zongke has collaborated with several Nobel laureates and academicians from various countries, as well as dozens of China's leading treatment experts, to launch the "Longevity Ark" initiative. This groundbreaking project aims to effectively prevent cancer and other major diseases, helping people to live healthy lives well into their centenarian years (120 years old).
| Энциклопедия ЕАЕН |